Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PBH Stock Forecast 2025-2026
$87.30
Current Price
$4.32B
Market Cap
Buy 3
Hold 3
Sell 1
Wall St Analyst Ratings
Distance to PBH Price Targets
+20.3%
To High Target of $105.00
+0.2%
To Median Target of $87.50
-11.8%
To Low Target of $77.00
PBH Price Momentum
+5.2%
1 Week Change
+6.3%
1 Month Change
+24.0%
1 Year Change
+11.8%
Year-to-Date Change
-3.0%
From 52W High of $90.04
+40.0%
From 52W Low of $62.35
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Prestige Healthcare (PBH) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on PBH and similar high-potential opportunities.
Latest PBH Stock Price Targets & Analyst Predictions
Based on our analysis of 9 Wall Street analysts, PBH has a neutral consensus with a median price target of $87.50 (ranging from $77.00 to $105.00). The overall analyst rating is Buy (7.4/10). Currently trading at $87.30, the median forecast implies a 0.2% upside. This outlook is supported by 3 Buy, 3 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PBH Analyst Ratings
3
Buy
3
Hold
1
Sell
PBH Price Target Range
Low
$77.00
Average
$87.50
High
$105.00
Current: $87.30
Latest PBH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PBH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 21, 2025 | RBC Capital | Ryland Conrad | Sector Perform | Maintains | $97.00 |
| Feb 13, 2025 | Oppenheimer | Rupesh Parikh | Outperform | Maintains | $93.00 |
| Feb 7, 2025 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $104.00 |
| Feb 7, 2025 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $100.00 |
| Nov 11, 2024 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $95.00 |
| Sep 24, 2024 | Jefferies | Stephanie Wissink | Hold | Assumes | $76.00 |
| Aug 28, 2024 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $95.00 |
| Aug 9, 2024 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $93.00 |
| Aug 9, 2024 | Canaccord Genuity | Buy | Maintains | $0.00 | |
| Jun 21, 2024 | DA Davidson | Linda Bolton Weiser | Buy | Upgrade | $93.00 |
| May 21, 2024 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $80.00 |
| May 16, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $65.00 |
| Jun 26, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Reiterates | $60.00 |
| May 8, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Reiterates | $60.00 |
| Mar 17, 2023 | RBC Capital | Sabahat Khan | Sector Perform | Maintains | $104.00 |
| Feb 17, 2023 | Oppenheimer | Rupesh Parikh | Outperform | Maintains | $71.00 |
| Jan 13, 2023 | Oppenheimer | Rupesh Parikh | Outperform | Maintains | $72.00 |
| Nov 17, 2022 | Canaccord Genuity | Susan Anderson | Buy | Initiates | $71.00 |
| May 10, 2022 | Jefferies | Stephanie Wissink | Buy | Upgrade | $70.00 |
| May 9, 2022 | Oppenheimer | Rupesh Parikh | Outperform | Upgrade | $63.00 |
Prestige Consumer Healthcare Inc. (PBH) Competitors
The following stocks are similar to Prestige Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
PBH
Prestige Consumer
mkt cap
4.32B
Prestige Consumer Healthcare Inc. (PBH) Financial Data
Prestige Consumer Healthcare Inc. has a market capitalization of $4.32B with a P/E ratio of 20.3x. The company generates $1.14B in trailing twelve-month revenue with a 18.9% profit margin.
Revenue growth is +7.1% quarter-over-quarter, while maintaining an operating margin of +34.0% and return on equity of +12.3%.
Valuation Metrics
Market Cap
$4.32B
Enterprise Value
$5.27B
P/E Ratio
20.3x
PEG Ratio
18.3x
Price/Sales
3.8x
Growth & Margins
Revenue Growth (YoY)
+7.1%
Gross Margin
+55.5%
Operating Margin
+34.0%
Net Margin
+18.9%
EPS Growth
+1.4%
Financial Health
Cash/Price Ratio
+2.3%
Current Ratio
4.2x
Debt/Equity
56.9x
ROE
+12.3%
ROA
+6.5%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Prestige Consumer Healthcare Inc. (PBH) Business Model
About Prestige Consumer Healthcare Inc.
What They Do
Produces and distributes over-the-counter healthcare products.
Business Model
The company generates revenue by producing and distributing a wide range of over-the-counter healthcare and household cleaning products. Its business model includes selling products through multiple channels such as drug stores, grocery stores, and e-commerce platforms, allowing it to reach a diverse consumer base effectively.
Additional Information
Prestige Consumer Healthcare Inc. operates within the consumer staples sector and plays a significant role in the healthcare, wellness, and personal care industries. The company offers various well-known brands across different categories, addressing everyday health and wellness needs.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
570
CEO
Mr. Ronald M. Lombardi CPA
Country
United States
IPO Year
2005
Website
www.prestigebrands.comPrestige Consumer Healthcare Inc. (PBH) Latest News & Analysis
Latest News
Quick Summary
Prestige Consumer Healthcare Inc. (NYSE: PBH) announced its fourth quarter and fiscal year financial results for the period ended March 31, 2025. Further details were not provided in the excerpt.
Why It Matters
Prestige Consumer Healthcare's financial results can indicate its growth, profitability, and market position, affecting stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
4 days ago
Quick Summary
Prestige Consumer Healthcare Inc. (NYSE:PBH) reported its financial results for Q4 and fiscal year ending March 31, 2025, on May 8, 2025.
Why It Matters
Prestige Consumer Healthcare's Q4 and fiscal year results can influence stock performance, investor sentiment, and future growth projections, impacting investment decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Prestige Consumer Healthcare (PBH) reported Q3 earnings of $1.32 per share, exceeding the Zacks estimate of $1.30 and up from $1.02 per share year-over-year.
Why It Matters
Prestige Consumer Healthcare's earnings beat expectations and show year-over-year growth, signaling strong financial performance and potential for stock price appreciation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Prestige Consumer Healthcare (PBH) reported its revenue and EPS for Q1 2025, which should be compared to Wall Street estimates and year-ago figures for deeper insights.
Why It Matters
Comparison of Prestige Consumer Healthcare's revenue and EPS against Wall Street estimates and prior year figures provides insights into growth, performance trends, and potential stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Insights Into Prestige Consumer Healthcare (PBH) Q4: Wall Street Projections for Key Metrics
5 days ago
Quick Summary
Analysts are evaluating key metrics for Prestige Consumer Healthcare (PBH) to assess its performance for the quarter ending March 2025, beyond just top and bottom-line estimates.
Why It Matters
Evaluating Prestige Consumer Healthcare's key metrics provides insights into operational performance and future growth potential, influencing investment decisions and stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Prestige Consumer Healthcare (PBH) Reports Next Week: Wall Street Expects Earnings Growth
11 days ago
Quick Summary
Prestige Consumer Healthcare (PBH) is not expected to have the necessary factors for a potential earnings beat in its upcoming report. Investors should prepare for this outcome.
Why It Matters
Prestige Consumer Healthcare may underperform in its earnings report, signaling potential risks for investors regarding stock performance and future growth prospects.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About PBH Stock
What is Prestige Consumer Healthcare Inc.'s (PBH) stock forecast for 2025?
Based on our analysis of 9 Wall Street analysts, Prestige Consumer Healthcare Inc. (PBH) has a median price target of $87.50. The highest price target is $105.00 and the lowest is $77.00.
Is PBH stock a good investment in 2025?
According to current analyst ratings, PBH has 3 Buy ratings, 3 Hold ratings, and 1 Sell ratings. The stock is currently trading at $87.30. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PBH stock?
Wall Street analysts predict PBH stock could reach $87.50 in the next 12 months. This represents a 0.2% increase from the current price of $87.30. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Prestige Consumer Healthcare Inc.'s business model?
The company generates revenue by producing and distributing a wide range of over-the-counter healthcare and household cleaning products. Its business model includes selling products through multiple channels such as drug stores, grocery stores, and e-commerce platforms, allowing it to reach a diverse consumer base effectively.
What is the highest forecasted price for PBH Prestige Consumer Healthcare Inc.?
The highest price target for PBH is $105.00 from at , which represents a 20.3% increase from the current price of $87.30.
What is the lowest forecasted price for PBH Prestige Consumer Healthcare Inc.?
The lowest price target for PBH is $77.00 from at , which represents a -11.8% decrease from the current price of $87.30.
What is the overall PBH consensus from analysts for Prestige Consumer Healthcare Inc.?
The overall analyst consensus for PBH is neutral. Out of 9 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 1 as Sell, with a median price target of $87.50.
How accurate are PBH stock price projections?
Stock price projections, including those for Prestige Consumer Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 12, 2025 4:38 AM UTC